Cardiomagnyl tablets film-coated

Land: Armenia

Språk: engelsk

Kilde: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Last ned Preparatomtale (SPC)
12-01-2018

Aktiv ingrediens:

acetylsalicylic acid, magnesium hydroxide

Tilgjengelig fra:

Takeda GmbH

ATC-kode:

B01AC30

INN (International Name):

acetylsalicylic acid, magnesium hydroxide

Dosering :

150mg+ 30,39mg

Legemiddelform:

tablets film-coated

Enheter i pakken:

(30) and (100) in glass container

Resept typen:

OTC

Autorisasjon status:

Registered

Autorisasjon dato:

2018-01-10

Preparatomtale

                                _1 _
_ _
SUMMARY OF PRODUCT CHARACTERISTICS
FOR
СARDIOMAGNYL, FILM COATED TABLETS 150 MG
1.
NAME OF THE MEDICINAL
PRODUCT
Cardiomagnyl
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 150 mg acetylsalicylic acid and 30,39mg
magnesium hydroxide
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablets
White oval film-coated tablets with a notch on one side
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Primary prophylaxis of cardiovascular disorders, such as thrombosis
and acute heart insufficiency
in high-risk patient groups (e.g. having diabetes mellitus,
hyperlipidemia, arterial hypertension,
obesity, smoking, and elderly age).
Prevention of recurrent myocardial infarction and vascular thrombosis.
Prevention
of
thromboembolism
after
surgical
intervention
on
blood
vessels
(aortocoronary
shunting, transdermal transluminal coronary angioplasty).
Unstable angina pectoris.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The tablets are to be swallowed whole with a drink of water. If
desired, a tablet can be broken into
two, chewed or triturated.
PRIMARY
PROPHYLAXIS
OF
CARDIOVASCULAR
DISORDERS,
SUCH
AS
THROMBOSIS
AND
ACUTE
HEART
INSUFFICIENCY
IN
HIGH-RISK
PATIENT
GROUPS
(E.G.
HAVING
DIABETES
MELLITUS,
HYPERLIPIDEMIA,
ARTERIAL HYPERTENSION, OBESITY, SMOKING, AND ELDERLY AGE)
One tablet of Cardiomagnyl containing 150 mg of ASA on day 1,
thereafter one tablet of
Cardiomagnyl containing 75 mg once daily.
_2 _
_ _
PREVENTION OF RECURRENT MYOCARDIAL INFARCTION AND VASCULAR THROMBOSIS
One tablet of cardiomagnyl containing 75-150 mg of ASA once daily.
PREVENTION OF THROMBOEMBOLISM AFTER SURGICAL INTERVENTION ON BLOOD
VESSELS (AORTOCORONARY
SHUNTING, TRANSDERMAL TRANSLUMINAL CORONARY ANGIOPLASTY)
One tablet of Cardiomagnyl containing 75-150 mg of ASA once daily.
UNSTABLE ANGINA PECTORIS
One tablet of Cardiomagnyl containing 75-150 mg of ASA once daily.
4.3
CONTRAINDICATIONS
Hypersensitivity to ASA, excipients of Cardiomagnyl, and other
non-steroidal anti-inflammatory
drugs;
cer
                                
                                Les hele dokumentet
                                
                            

Dokumenter på andre språk

Informasjon til brukeren Informasjon til brukeren russisk 10-01-2018
Preparatomtale Preparatomtale russisk 27-05-2024
Preparatomtale Preparatomtale armensk 27-05-2024